Home » Topics » Vertex Pharmaceuticals
U.S. approves new drug for rare cystic fibrosis
WASHINGTON — US regulators on Tuesday approved Kalydeco, a new, gene-targeted drug treatment for people who have a rare kind of the incurable lung disease cystic fibrosis. Made by the Massachusetts-based Vertex Pharmaceuticals, Kalydeco (ivacaftor) was approved by the US Food and Drug Administration on a fast-track for drugs that…
Brand new on Raw Story
- Jon Stewart rips Obama for aggressive investigation of whistle-blowers instead of bankers
- WATCH LIVE: Rescue operation begins as Washington state bridge collapses
- Senate unanimously approves Sri Srinivasan as first India-born senior judge
- Republican congressman fined $500 over sexual misconduct
- Anthony Weiner’s mayoral campaign off to a rocky start after police called to rally
- George Zimmerman lawyers release Trayvon Martin’s cellphone data to discredit killed teen
- IRS director Lois Lerner placed on administrative leave
- Questions Obama dodged in terror speech
- Texas Gov. Rick Perry ‘greatly disappointed’ by vote to admit openly gay Boy Scouts
- Boy Scouts to allow gay members but ban on gay and atheist leaders continues
Commentary
The real problem with 'check your privilege': It’s too generous
By Amanda Marcotte
The reality is Americans aren’t that concerned about drones
By Harry Enten, The Guardian
Tone policing only goes one way
By Amanda Marcotte
Raw Exclusives
Featured Video
Follow Us!
